3Zhang FR, Huang W, Chen SM, et al. Genomewide association study of leprosy. N Engl J Meal, 2009,361 (27) :2609-2618.
4Lavado-Valenzuela R, Jos6 Bravo M, Junqueira-Kipnis AP, et al. Distribution of the HLA class II frequency alleles in patients withleprosy from the mid-west of Brazil. Int J Immunogenet,2011,38 (3) :255-258.
5Moet FJ, Pahan D, Schuring RP, et al. Physical distance, genetic relationship, age, and leporsy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis, 2006, 193(2) :346-353.
6Ishii N, Sugita Y, Nakajima H. Two sisters with leprosy. J Dermatol, 1993, 20 (4) :226-230.
7Shankarkumar U, Ghosh K, Badakere S, et al. Novel HLA Class I Alleles Associated with Indian Leprosy Patients. J Biomed Biotechnol, 2003, 2003 ( 3 ) :208-211.
8Honeybome I, Prendergast A, Pereyra F, et al. Control of human immunodefibiency virus type 1 is assoeiated with HLA-B * 13 and targeting of multiple gag-specific CD8 + T-cell epitopes. J Virol, 2007, 81 (7) :3667-3672.
9Prado JG, Honeyborue I, Brierley I, et al. Functional consequences of human immunodefieiency virus escape from an HLA-B * 13-restricted CD8 + T-cell epitope in pl Gag protein. J Virol, 2009, 83 (2) : 1018-1025.
10Stephens HA, Klaythong R, Sirikong M, et al. HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens,2002, 60(4) :309-318.
